321 related articles for article (PubMed ID: 33668341)
1. Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts.
Fernandes F; Dias-Teixeira M; Delerue-Matos C; Grosso C
Nanomaterials (Basel); 2021 Feb; 11(3):. PubMed ID: 33668341
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of
Costa CP; Moreira JN; Sousa Lobo JM; Silva AC
Acta Pharm Sin B; 2021 Apr; 11(4):925-940. PubMed ID: 33996407
[TBL] [Abstract][Full Text] [Related]
4. Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters.
Amiri M; Jafari S; Kurd M; Mohamadpour H; Khayati M; Ghobadinezhad F; Tavallaei O; Derakhshankhah H; Sadegh Malvajerd S; Izadi Z
ACS Chem Neurosci; 2021 Dec; 12(24):4475-4490. PubMed ID: 34841846
[TBL] [Abstract][Full Text] [Related]
5. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
[TBL] [Abstract][Full Text] [Related]
6. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme.
Jnaidi R; Almeida AJ; Gonçalves LM
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927610
[TBL] [Abstract][Full Text] [Related]
7. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
Cunha S; Amaral MH; Lobo JMS; Silva AC
Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
[TBL] [Abstract][Full Text] [Related]
8. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.
Tapeinos C; Battaglini M; Ciofani G
J Control Release; 2017 Oct; 264():306-332. PubMed ID: 28844756
[TBL] [Abstract][Full Text] [Related]
9. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors.
Mehrdadi S
Adv Pharm Bull; 2023 Jul; 13(3):512-520. PubMed ID: 37646057
[TBL] [Abstract][Full Text] [Related]
10. Transferrin-functionalized lipid nanoparticles for curcumin brain delivery.
Neves AR; van der Putten L; Queiroz JF; Pinheiro M; Reis S
J Biotechnol; 2021 Apr; 331():108-117. PubMed ID: 33727082
[TBL] [Abstract][Full Text] [Related]
11. The Complexity of the Blood-Brain Barrier and the Concept of Age-Related Brain Targeting: Challenges and Potential of Novel Solid Lipid-Based Formulations.
Sommonte F; Arduino I; Racaniello GF; Lopalco A; Lopedota AA; Denora N
J Pharm Sci; 2022 Mar; 111(3):577-592. PubMed ID: 34469749
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery.
Nguyen TT; Maeng HJ
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335948
[TBL] [Abstract][Full Text] [Related]
14. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
15. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
16. Optimized Nanoparticles for Enhanced Oral Bioavailability of a Poorly Soluble Drug: Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers.
Darwish MKM; El-Enin ASMA; Mohammed KHA
Pharm Nanotechnol; 2022; 10(1):69-87. PubMed ID: 35142275
[TBL] [Abstract][Full Text] [Related]
17. Intranasal lipid nanoparticles for the treatment of neurodegenerative diseases.
Cunha S; Almeida H; Amaral MH; Lobo JMS; Silva AC
Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29189138
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
19. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization.
Nafee N; Makled S; Boraie N
Eur J Pharm Sci; 2018 Dec; 125():151-162. PubMed ID: 30292750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
